Implementation of the European multicentre database of healthy controls for [123I]FP-CIT SPECT increases diagnostic accuracy in patients with clinically uncertain parkinsonian syndromes-Reference-Cited by-同舟云学术

Implementation of the European multicentre database of healthy controls for [123I]FP-CIT SPECT increases diagnostic accuracy in patients with clinically uncertain parkinsonian syndromes

Published:2016-01-18 Issue:7 Volume:43 Page:1315-1322
ISSN:1619-7070
Container-title:European Journal of Nuclear Medicine and Molecular Imaging
language:en
Short-container-title:Eur J Nucl Med Mol Imaging

Author:

Albert Nathalie L.,Unterrainer Marcus,Diemling Markus,Xiong Guoming,Bartenstein Peter,Koch Walter,Varrone Andrea,Dickson John C.,Tossici-Bolt Livia,Sera Terez,Asenbaum Susanne,Booij Jan,Kapucu L. Özlem Atay,Kluge Andreas,Ziebell Morten,Darcourt Jacques,Nobili Flavio,Pagani Marco,Sabri Osama,Hesse Swen,Borght Thierry Vander,Van Laere Koen,Tatsch Klaus,la Fougère Christian

Publisher

Springer Science and Business Media LLC

Subject

Radiology, Nuclear Medicine and imaging,General Medicine,Radiology, Nuclear Medicine and imaging,General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s00259-015-3304-2.pdf

Reference26 articles.

1. Suwijn SR, van Boheemen CJ, de Haan RJ, Tissingh G, Booij J, de Bie RM. The diagnostic accuracy of dopamine transporter SPECT imaging to detect nigrostriatal cell loss in patients with Parkinson’s disease or clinically uncertain parkinsonism: a systematic review. EJNMMI Res. 2015;5:12. doi: 10.1186/s13550-015-0087-1 .

2. Benamer HTS, Patterson J, Grosset DG, Booij J, de Bruin K, van Royen E, et al. Accurate differentiation of parkinsonism and essential tremor using visual assessment of [123I]-FP-CIT SPECT imaging: The [123I]-FP-CIT study group. Mov Disord. 2000;15:503–10. doi: 10.1002/1531-8257(200005)15:3<503::AID-MDS1013>3.0.CO;2-V .

3. Darcourt J, Booij J, Tatsch K, Varrone A, Borght T, Kapucu Ö, et al. EANM procedure guidelines for brain neurotransmission SPECT using 123I-labelled dopamine transporter ligands, version 2. Eur J Nucl Med Mol Imaging. 2010;37:443–50. doi: 10.1007/s00259-009-1267-x .

4. McKeith I, O’Brien J, Walker Z, Tatsch K, Booij J, Darcourt J, et al. Sensitivity and specificity of dopamine transporter imaging with 123I-FP-CIT SPECT in dementia with Lewy bodies: a phase III, multicentre study. Lancet Neurol. 2007;6:305–13. doi: 10.1016/S1474-4422(07)70057-1 .

5. Booij J, Speelman J, Horstink MIM, Wolters E. The clinical benefit of imaging striatal dopamine transporters with [123I]FP-CIT SPET in differentiating patients with presynaptic parkinsonism from those with other forms of parkinsonism. Eur J Nucl Med. 2001;28:266–72. doi: 10.1007/s002590000460 .

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cross-Tracer and Cross-Scanner Transfer Learning-Based Attenuation Correction for Brain SPECT;IEEE Transactions on Radiation and Plasma Medical Sciences;2024-07

2. Robustness of radiomic features in 123I-ioflupane-dopamine transporter single-photon emission computer tomography scan;PLOS ONE;2024-04-11

3. Automated identification of uncertain cases in deep learning-based classification of dopamine transporter SPECT to improve clinical utility and acceptance;European Journal of Nuclear Medicine and Molecular Imaging;2023-12-22

4. Metabolic network alterations as a supportive biomarker in dementia with Lewy bodies with preserved dopamine transmission;European Journal of Nuclear Medicine and Molecular Imaging;2023-11-16

5. Quantitative [123]I-Ioflupane DaTSCAN single-photon computed tomography-computed tomography in Parkinsonism;Nuclear Medicine Communications;2023-07-03